《瑞銀窩輪》市場擔心疫情恆指蒸發12月升幅 資金留意阿里購18434
肺炎疫情擴散全國令市場憂慮，恆指農曆新年後復市連跌三日，上週五跌下試26300點低位，大市成交金額超過900億港元，全日波幅超過500點。 近星期熱炒的新經濟股不少受市場氣氛拖累而向下，騰訊(0700)股價最低見371.4港元，阿里巴巴(9988)股價則曾再失守200港元。現時阿里巴巴的10天線位於215港元的位置，投資者可留意股價能否重上此水平之上。另外根據彭博資訊，阿里巴巴將於2月13日公布業績，資金開始留意認股證作部署。如投資者看好阿里，可留意阿里巴巴認購18434，行使價226.19港元，20年5月到期，有效槓桿約8.8倍。相反，如投資者看淡阿里，可留意阿里巴巴認沽17823，行使價195港元，20年7月到期，有效槓桿約7.1倍。
而新經濟股中亦有走強的股份，要數美團(3690)。美團當日再次上試1000港元關口，收市亦升超過2%。不過由於不少市場分析認為內地疫情加劇有機會嚴重打擊美團的餐飲、旅遊訂位等服務，所以上週五美團股價上升時，不少投資者反手買入美團認沽證。如投資者看淡美團，可留意美團點評認沽14038，行使價98.23港元，20年4月到期，有效槓桿約6.9倍。
另外，由於大市仍充斥不明朗因素，如投資者希望部署大市，亦可轉為考慮認股證選擇。如投資者看好恆指，可留意恆指認購12947，行使價28300點，20年4月到期，有效槓桿約18.倍。如投資者看淡恆指，可留意恆指認沽13601，行使價26400點，20年4月到期，有效槓桿約12.倍。
更多窩輪牛熊資訊：瑞銀證網站: www.ubs.com/hkwarrant
窩證教學及巿況焦點短片:
https://www.youtube.com/channel/UCKw86qy4eBAInmd52MND45Q?view_as=subscriber卓素華董事
瑞銀亞洲股票衍生產品銷售部
本產品並無抵押品。 如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。筆者為UBS AG的代表(作為證監會持牌人)，並未持有相關上市公司的任何財務權益。本資料由瑞銀刊發，其並不構成買賣建議、邀請、要約或遊說。結構性產品價格可急升或急跌，投資者可能會蒙受全盤損失。過往表現並不反映將來表現。牛熊證備強制贖回機制而可能被提早終止，屆時 (i) N類牛熊證投資者將不獲發任何金額;而(ii) R類牛熊證之剩餘價值可能為零。投資前應瞭解有關風險，並諮詢專業顧問及查閱有關上市文件。UBS Securities Hong Kong Limited為結構性產品之流通量提供者，亦可能是唯一報價者或巿場參與者。(C) UBS 2020。版權所有。~重要聲明:
以上資訊由第三方提供，AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告，不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料，本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
